Serum Prolidase Activity and Oxidative Status in Patients With Stage I Endometrial Cancer

Introduction: We aimed to investigate the serum prolidase activity, total oxidant status (TOS), total antioxidant capacity (TAC), and total free sulfhydryl (-SH) groups in patients with stage I endometrial cancer. Methods: Serum prolidase activity, TOS, TAC, and -SH levels were measured in patients with endometrial cancer (n = 23) and controls (n = 25). Results: Serum prolidase activity and TOS were significantly higher in patients with endometrial cancer than in controls (P = 0.02 and P = 0.02, respectively), whereas TAC and -SH group levels were significantly lower (P = 0.004 and P = 0.001, respectively). There were no differences between surgical stages IA and IB or between stages IB and IC (P = 0.189 and P = 0.161, respectively) with respect to prolidase levels, whereas there was a significant difference between stages IA and IC (P < 0.001). Conclusions: Increased serum prolidase activity and oxidative stress may be associated with endometrial cancer, and increased serum prolidase activity may be related to local invasion of endometrial cancer.

[1]  H. Çelik,et al.  Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer. , 2009, Gynecologic oncology.

[2]  K. Salnikow,et al.  Extracellular matrix and HIF‐1 signaling: The role of prolidase , 2008, International journal of cancer.

[3]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[4]  M. Manabe,et al.  Prolidase Isoenzymes in the Rat: Their Organ Distribution, Developmental Change and Specific Inhibitors , 2007, Pediatric Research.

[5]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[6]  H. Çelik,et al.  Increased oxidative stress and its relation with collagen metabolism in knee osteoarthritis , 2007, Rheumatology International.

[7]  M. Wojtukiewicz,et al.  Enhanced prolidase activity and decreased collagen content in breast cancer tissue , 2006, International journal of experimental pathology.

[8]  J. Kasapović,et al.  Lipid peroxidation and antioxidant status in blood of patients with uterine myoma, endometrial polypus, hyperplastic and malignant endometrium. , 2006, Biological research.

[9]  M. Keleş,et al.  Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. , 2005, Cancer letters.

[10]  S. Ricard-Blum,et al.  The collagen superfamily: from the extracellular matrix to the cell membrane. , 2005, Pathologie-biologie.

[11]  T. Guszczyn,et al.  Deregulation of Collagen Metabolism in Human Stomach Cancer , 2004, Pathobiology.

[12]  O. Erel,et al.  A novel automated method to measure total antioxidant response against potent free radical reactions. , 2004, Clinical biochemistry.

[13]  S. Manoharan,et al.  Enhanced lipid peroxidation and impaired enzymic antioxidant activities in the erythrocytes of patients with cervical carcinoma. , 2004, Cellular & molecular biology letters.

[14]  E. Karna,et al.  Prolidase activity disregulation in chronic pancreatitis and pancreatic cancer. , 2002, Hepato-gastroenterology.

[15]  Y. Ozkan,et al.  Plasma malondialdehyde (MDA) levels in breast and lung cancer patients , 2001, Journal of clinical pharmacy and therapeutics.

[16]  E. Karna,et al.  Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale , 2000, International journal of experimental pathology.

[17]  L. Marnett,et al.  Oxyradicals and DNA damage. , 2000, Carcinogenesis.

[18]  J. Phang,et al.  Prolidase in human breast cancer MCF-7 cells. , 1998, Cancer letters.

[19]  J. Phang,et al.  Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors , 1997, Journal of cellular biochemistry.

[20]  S. Loft,et al.  Cancer risk and oxidative DNA damage in man , 1997, Journal of Molecular Medicine.

[21]  M. Duffy,et al.  Proteases as prognostic markers in cancer. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  C. Cross,et al.  Antioxidant protection against hypochlorous acid in human plasma. , 1993, The Journal of laboratory and clinical medicine.

[23]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[24]  I. Myara,et al.  Prolidase and prolidase deficiency. , 1984, Life sciences.

[25]  I. Myara,et al.  Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. , 1984, Clinical chemistry.

[26]  I. Myara,et al.  Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. , 1982, Clinica chimica acta; international journal of clinical chemistry.